NTL Record

Title Narcolepsy (with and without Cataplexy) and Commercial Motor Vehicle Driver Safety
Record ID 55225
Personal Name
Creator
Bieber-Tregear, Michelle; Williams, Jessica Roberts; Tregear, Stephen
Corporate Creator MANILA Consulting Group, Inc.
Publisher United States. Department of Transportation. Federal Motor Carrier Safety Administration
Publication Date 20091000
Language English
Abstract The purpose of this evidence report is to address several questions posed by FMCSA regarding the topic of narcolepsy and commercial motor vehicle (CMV) driver safety. In the early scope development work conducted by the Agency and the Medical Review Board (MRB), the following issues of concern were raised: 1. Does narcolepsy result in an increased risk of CMV crash? Does narcolepsy result in an increased risk of personal vehicle crash? 2. Is there experimental evidence that narcolepsy results in driving impairment (e.g., driving simulator studies)? 3. Is there quality evidence that treatment of narcolepsy reduces risk of crash to that of the appropriately certified CMV driving population? Is there quality evidence that treatment of narcolepsy reduces risk of personal vehicle crashes to that of the healthy general driving population? 4. Does use of modafinil to treat narcolepsy reduce risk of crash to that of the appropriately certified CMV driving population? Does use of modafinil for treatment of narcolepsy reduce risk of personal vehicle crash to that of the healthy general driving population?
Rosap ID dot:29009
Rosap URL https://rosap.ntl.bts.gov/view/dot/29009
TRT Terms Narcolepsy; Commercial drivers; Traffic crashes; Highway safety; Literature reviews
Geographical
Coverage
United States
TRIS Online
Accession No
1575244
Contract Number GS-10F-0177N/DTMC75-06- F-00039
Resource type Tech Report
URL https://ntlrepository.blob.core.windows.net/lib/55000/55200/55225/Narcolepsy_and_CMV_drivers_-_FINAL_10302009..pdf
Format PDF
Database NTL Digital Repository